Bioética e investigación: análisis de caso de la epidemia por el virus del ébola en 2014
Resumen
La epidemia por el virus Ébola en África occidental (2014) ha suscitado una serie de interrogantes éticos en torno a las medidas de salud pública para su contención, el uso de medicamentos experimentales y el desarrollo de vacunas contra esta enfermedad. El presente trabajo explora algunas de estas preguntas desde la perspectiva de la ética en investigación biomédica. La epidemia por el virus Ébola es un modelo de estudio adecuado para abordar esfuerzos multilaterales en investigación, así como para analizar aspectos antropológicos en salud pública y determinantes sociales, económicos y políticos en salud a nivel global.
Descargas
Disciplinas:
Bioética, ética en investigación, humanidades, salud pública,Lenguajes:
esAgencias de apoyo:
Universidad del RosarioReferencias bibliográficas
Adebamowo, C., Bah-Sow, O., Binka, F., Bruzzone, R. et al. (2014). Randomised controlled trials for Ebola: practical and ethical issues. The Lancet, 384(9952), 1423-4. https://doi.org/10.1016/S0140-6736(14)61734-7
Asociación Médica Mundial [AMM]. (2013). Declaración Helsinki, Principios éticos para las investigaciones médicas en seres humanos. 64ª Asamblea General. Fortaleza, Brasil.
Bausch, D.G., Sprecher, A.G., Jeffs, B., Boumandouki, P. (2008). Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions. Antiviral Research, 78(1), 150-161. https://doi.org/10.1016/j.antiviral.2008.01.152
Benatar, S. (2015). Explaining and responding to the Ebola epidemic. Philosophy, Ethics, and Humanities in Medicine, 10(5), 1-3. https://doi.org/10.1186/s13010-015-0027-8
Bogoch, I.I., Creatore, M.I., Cetron, M.S., Brownstein, J.S. et al. (2015). Assessment of the potential for international dissemination of Ebola virus via commercial air travel during the 2014 west African outbreak. Lancet, 3(9962), 29-35. https://doi.org/10.1016/S0140-6736(14)61828-6
Boozary, A.S., Farmer, P.E. y Jha, A.K. (2014). The Ebola Outbreak, Fragile Health Systems, and Quality as a Cure. Journal of the American Medical Association, 312(18), 1859-1860. https://doi.org/10.1001/jama.2014.14387
Caplan, A.L., Plunkett, C. y Levin, B. (2015). Selecting the right tool for the job. The American Journal of Bioethics, 15(4), 4-10. https://doi.org/10.1080/15265161.2015.1010993
Centers for Disease Control and Prevention [CDC] (2015a). Ebola (Ebola Virus Disease). Recuperado el 12 de noviembre de 2015, de http://www.cdc.gov/vhf/Ebola/transmission/index.html
Centers for Disease Control and Prevention [CDC] (2015b). Enfermedad del virus del Ebola. Prevención. Recuperado el 18 de noviembre de 2015, de http://espanol.cdc.gov/vhf/ebola/prevention/index.html
Check, E. (2015). Proposed Ebola biobank would strengthen African science. Nature, 524(7564), 146-147. https://doi.org/10.1038/524146a
Coffey, C.S., Levin, B., Clark. C., Timmerman, C. et al. (2012). Overview, hurdles, and future work in adaptive designs: Perspectives from an NIH funded workshop. Clinical Trials, 9(6), 671-680. https://doi.org/10.1177/1740774512461859
Cohen, J. y Kupferschmidt, K. (2014). Ebola vaccine trials raise ethical issues: Randomized studies may offer fastest answer. Science Magazine, 346(6207), 289-290. https://doi.org/10.1126/science.346.6207.289
Council for International Organizations of Medical Sciences [CIOMS] y World Health Organization [WHO] (2002). Pautas éticas internacionales para la investigación y experimentación biomédica en seres humanos de la Organización Mundial de la Salud. Ginebra, pauta número 12. Recuperado el 21 de marzo de 2016, de http://www.cioms.ch/publications/guidelines/pautas_eticas_internacionales.htm
Cox, E., Borio, L. y Temple R. (2014). Evaluating Ebola therapies. The case for RCTs. New England Journal of Medicine, 371(25), 2350-2351. https://doi.org/10.1056/NEJMp1414145
Deaton, A. (2015). El gran escape. Salud, riqueza y el origen de la desigualdad. Madrid: Fondo de Cultura Económica.
Donovan, G.K. (2014). Ebola, epidemics, and ethics. What we have learned? Philosophy, Ethics and Humanities in Medicine, 9(15), 2-4. https://doi.org/10.1186/1747-5341-9-15
Emanuel, E. (1999). ¿Qué hace que la investigación clínica sea ética? Siete requisitos éticos. En A. Pellegrini Filho y R. Macklin (Eds.), Investigación en sujetos humanos: experiencia internacional (pp. 33-46). Santiago: Organización Panamericana de la Salud.
Emanuel, E.J., Wendler, D. y Grady, C. (2008). An Ethical Framework for Biomedical Research. En J. Emanuel, C. Grady, R. Crouch, R. y F. Lie (Eds.), The Oxford textbook of clinical research ethics. Oxford: Oxford University Press.
Farmer, P.E. (2014). Diary. London Review of Books, 36(20), 38-39. Recuperado el 18 de diciembre de 2015, de http://www.lrb.co.uk/v36/n20/paul-farmer/diary
Feldmann, H., Klenk, H.D. y Sanchez, A. (1993). Molecular biology and evolution of filoviruses. Archives Virology, 7, 81-100. https://doi.org/10.1007/978-3-7091-9300-6_8
Frieden, T.R., Damon, I., Bell, B.P., Kenyon, T. y Nichol, S. (2014). Ebola 2014. New Challenges, New Global Response and Responsibility. New England Journal of Medicine, 371, 1177-1180. https://doi.org/10.1056/NEJMp1409903
Folayan, M.O. y Haire, B. (2015). Ethical considerations in the conduct of research on therapies for the prevention and treatment of Ebola virus disease in developing countries. Pan African Medical Journal, 22(Suppl 1), 8.
Folayan, M.O, Peterson, K. y Kombe, F. (2015). Ethics, emergencies and Ebola clinical trials: the role of governments and communities in offshored research. Pan African Medical Journal, 22(Supp 1), 10.
Folayan, M.O., Yakubu, A., Haire, B., Peterson, K. (2016). Ebola vaccine development plan: ethics, concerns and proposed measures. BMC Medical Ethics, 17(10). https://doi.org/10.1186/s12910-016-0094-4
Gehring, G., Rohrmann, K., Atenchong, N. y Mittler, E. (2014). The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry. Journal of Antimicrobial Chemotherapy, 69(8), 2123-31. https://doi.org/10.1093/jac/dku091
Gericke, C.A. (2015). Ebola and ethics: autopsy of a failure. BMJ, 350, h2105. https://doi.org/10.1136/bmj.h2105
Gostin, L.O., Lucey, D. y Phelan, A. (2014). The Ebola Epidemic: A Global Health Emergency. JAMA, 312(11), 1095-1096. https://doi.org/10.1001/jama.2014.11176
Griffiths, P.D. (2014). Ebola and ethics. Reviews in Medical Virology, 24(6), 363-364. https://doi.org/10.1002/rmv.1812
Hayden, E.C. (2014). Ethical dilemma for Ebola drug trials. Nature, 515(7526), 177-178. https://doi.org/10.1038/515177a
Instituto de Salud Global de Barcelona [ISGlobal]. (2016). Ébola: dos a-os y 11 300 muertes después. Recuperado el 17 de marzo de 2016, de http://www.isglobal.org/Ebola
Jecker, N.S., Dudzinski, D.M., Diekema, D.S. y Tonelli, M. (2015). Ebola virus disease. Ethics and emergency medical response policy. Chest, 148(3), 794-800. https://doi.org/10.1378/chest.15-0135
Joffe, S. (2014). Evaluating novel therapies during the Ebola Epidemic. JAMA, 312(13), 1299-1300. https://doi.org/10.1001/jama.2014.12867
Kass, N. (2014). Ebola, Ethics, and Public Health: What Next? Annals of Internal Medicine, 161(10), 744-745. https://doi.org/10.7326/M14-1864
Kilgore, P.E., Grabenstein, J.D., Salim, A.M., Rybak, M. (2015). Treatment of Ebola virus disease. Pharmacotherapy, 35(1), 43-53. https://doi.org/10.1002/phar.1545
Komesaroff, P. y Kerridge. I. (2014). Ebola, Ethics, and the question of culture. Journal of Bioethical Inquiry, 11(4), 413-414. https://doi.org/10.1007/s11673-014-9581-9
Kroll, D. (2014). Ebola 'Secret Serum': Small Biopharma, the army and Big Tobacco. Forbes-Pharma and Healthcare. Recuperado el 3 de marzo de 2016, de http://www.forbes.com/sites/davidkroll/2014/08/05/Ebola-secret-serum-small-biopharma-the-army-and-big-tobacco/
Lazcano-Ponce, E., Salazar-Martínez, E., Gutiérrez-Castrellón, P., Angeles-Llerenas, A. et al. (2004). Ensayos clínicos aleatorizados: variantes, métodos de aleatorización, análisis, consideraciones éticas y regulación. Salud Pública de México, 46(6), 559-584. https://doi.org/10.1590/S0036-36342004000600012
Lyon, G.M., Mehta, A.K., Varkey, J.B., Brantly, K., et al. (2014). Clinical Care of Two Patients with Ebola Virus Disease in the United States. New England Journal of Medicine, 371(25), 2402-2409. https://doi.org/10.1056/NEJMoa1409838
Mackenzie, C., Rogers, W. y Dodds, S. (2014). Vulnerability. New Essays in Ethics and Feminist Philosophy. New York: Oxford University Press.
Mapp Biopharmaceutical. (2014). ZMapp information sheet. Recuperado el 3 de marzo de 2016, de http://www.defyrus.com/images/ZMapp-information-sheet.pdf
Marí Sáez, A., Kelly, A. y Brown, H. (2014). Apuntes sobre el paciente cero: antropología en los tiempos del Ébola. La marea.com. Recuperado el 21 de marzo de 2016, de http://www.lamarea.com/2014/10/09/apuntes-sobre-el-caso-paciente-cero-antropologia-en-los-tiempos-del-ebola/
Marí Sáez, A., Weiss, S., Nowak, K, et al. (2015). Investigating the zoonotic origin of the West African Ebola epidemic. EMBO Molecular Medicine, 7, 17-23. https://doi.org/10.15252/emmm.201404792
Mathers, C.D., Boerma, T. y Ma Fat, D. (2009). Global and regional causes of death. British Medical Bulletin, 92, 7-32. https://doi.org/10.1093/bmb/ldp028
Mathers, C.D. y Loncar, D. (2006). Projections of Global Mortality and Burden of Disease from 2002 to 2030. PLoS Medicine, 3(11), e442. https://doi.org/10.1371/journal.pmed.0030442
McCarthy, M. (2014). US signs contract with ZMapp maker to accelerate development of the Ebola drug. BMJ, 349, g5488. https://doi.org/10.1136/bmj.g5488
Mehta, A.K., Varkey, J.B., Brantly, K., Pérez, C.E. y Faccini-Martínez, A.A. (2015). Epidemia de Ebola-201: enfocar los esfuerzos en el control desde su epicentro. Revista Panamericana de Infectología, 17(1), 5-6.
Meltzer, L. y Childress, J. (2008). What is a fair participant selection? (capítulo 35) En E. J. Emanuel, C. Grady, R. Crouch et al. (Eds.), The Oxford textbook of clinical research ethics (pp. 377-383). Oxford: Oxford University Press.
Mickleburgh, S., Waylen, K. y Racey, P. (2009). Bats as bushmeat: a global review. Oryx, 43, 217-234. https://doi.org/10.1017/S0030605308000938
Morley, F. y Macleod, R. (2015). The Halifax Index 2015. An economic gut check with insights for action. (2015). Halifax partnership. Connect, collaborate, prosper. Recuperado el 21 de marzo de 2016, de http://www.halifaxpartnership.com/site/media/Parent/8x10_HalifaxIndex2015_June18_Web.pdf
Murray, C.J.L., Rosenfeld, L.C., Lim, S.S., Andrews, K.G. et al. (2012). Global malaria mortality between 1980 and 2010: a systematic analysis. The Lancet, 379(9814), 413-431.https://doi.org/10.1016/S0140-6736(12)60034-8
Nkoghé, D., Formenty, P., Nnégué, S., Toung Mvé, M. et al. (2004). Recommandations pratiques pour la prise en charge sur le terrain des patients infectés par le virus Ebola. Médecine Tropicale, 64(2), 199-204.
Organización Mundial de la Salud [OMS] (2014a). Consideraciones éticas sobre el uso de intervenciones no registradas en la enfermedad por el virus del Ébola. Recuperado el 12 de octubre de 2015, de http://www.who.int/mediacentre/news/statements/2014/Ebola-ethical-review-summary/es/
Organización Mundial de la Salud [OMS] (2014b). Statement on the WHO Consultation on potential Ebola therapies and vaccines. Recuperado el 21 de marzo de 2016, de http://www.who.int/mediacentre/news/statements/2014/Ebola-therapies-consultation/en/
Organización Mundial de la Salud [OMS]. (2015a). Ebola Virus Disease. Recuperado el 26 de febrero de 2016, de http://www.who.int/mediacentre/factsheets/fs103/en/
Organización Mundial de la Salud [OMS] (2015b). Ebola Situation Reports. Recuperado el 15 de diciembre de 2015, de http://apps.who.int/Ebola/Ebola-situation-reports
Organización Mundial de la Salud [OMS] (2015c). Ebola data and satistics. Key indicators relevant to Ebola outbreak. Recuperado el 12 de noviembre de 2015, de http://apps.who.int/gho/data/node.Ebola.keyind?lang=en
Pinto, B.J., Mojica, M.C., Gulfo, R., Endo, J.H., y Idárraga, J. (2014). Bioética y la brecha 10/90: fallos, desafíos y oportunidades. Revista Redbioética, 2(10), 81-93.
Presidential Commission for the Study of Bioethical Issues. (2015). Ethics and Ebola Public Health Planning and Response. Recuperado el 16 de diciembre de 2015, de http://bioethics.gov/sites/default/files/Ethics-and-Ebola_PCSBI_508.pdf
Programa Conjunto de las Naciones Unidas sobre el VIH/SIDA [ONUSIDA] (2015) Diapositivas clave sobre epidemiología, julio 2015. Recuperado el 19 de julio de 2015, de http://www.unaids.org/sites/default/files/media_asset/20150714_epi_core_es.pdf
Pourrut, X., Kumulungui, B., Wittmann, T., Moussavou, G. et al. (2005). The natural history of Ebola virus in Africa. Microbes and Infection, 7(7-8), 1005-1014. https://doi.org/10.1016/j.micinf.2005.04.006
Qiu, X., Wong, G., Audet, J., Bello, A. et al. (2014). Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature, 514(7520), 47-53. https://doi.org/10.1038/nature13777
Rid, A y Emanuel, E. (2014a). Why Should High-Income Countries Help Combat Ebola? JAMA, 312(13), 1297-1298. https://doi.org/10.1001/jama.2014.12869
Rid, A. y Emanuel, E. (2014b). Ethical considerations of experimental interventions in the Ebola outbreak. The Lancet, 384(9957), 1896-1899. https://doi.org/10.1016/S0140-6736(14)61315-5
Rid, A. y Miller, F. (2016). Ethical Rationale for the Ebola "Ring Vaccination" Trial Design. American Journal of Public Health, 106(3), 432-5. https://doi.org/10.2105/AJPH.2015.302996
Roberts, I. y Perner, A. (2014). Ebola virus disease: clinical care and patient-centred research. The Lancet, 384, 2001-2002. https://doi.org/10.1016/S0140-6736(14)62316-3
Shah, S., Wendler, D. y Danis, M. (2015). Examining the ethics of clinical use of unproven interventions outside of clinical trials during the Ebola epidemic. The American Journal of Bioethics, 15(4), 11-16. https://doi.org/10.1080/15265161.2015.1010996
Shaul, R.Z., Langer, J.C., McKneally, M.F. (2008). Innovación en cuidados médicos: ejemplos de cirugía. En A. Singer Peter y A. Viens (Eds.), The Cambridge Textbook of Bioethics. New York: Cambridge University Press.
Simonsen, S. (2012). Acceptable Risk in Biomedical Research. European Perspectives. Netherlands: Springer Science+Business Media. https://doi.org/10.1007/978-94-007-2678-9
Smith, D.I.H. (1978). Ebola haemorrhagic fever in Sudan, 1976. Bulletin of the World Health Organization, 56(2), 247–270
Taber, J. (2014). Hundreds of Nova Scotians volunteer for Ebola vaccine trial. The Globe and Mail. Recuperado el 21 de marzo de 2016, de http://www.theglobeandmail.com/life/health-and-fitness/health/hundreds-of-nova-scotians-volunteer-for-Ebola-vaccine-trial/article21712654
United Nations Development Group [UNDG], Western and Central Africa. (2015). Socio-Economic Impact of Ebola Virus Disease in West African Countries. A call for national and regional containment, recovery and prevention. United Nations Development Group. Recuperado el 16 de noviembre de 2015, de https://undg.org/main/undg_document/socio-economic-impact-of-ebola-virus-disease-in-west-african-countries/
Waldman, R. y Nieburg, P. (2015). Thoughts on Alternative Designs for Clinical Trials for Ebola Treatment Research. The American Journal of Bioethics, 15(4), 38-40. https://doi.org/10.1080/15265161.2015.1011001
Yozwiak, N.L., Schaffner S.F. y Sabeti, P.C. (2015). Make outbreak research open access. Nature, 518, 477-479. https://doi.org/10.1038/518477a
World Health Organization Ebola Response Team[WHO-ERT] (2014). Ebola Virus Disease in West Africa - the First 9 Months of the Epidemic and Forward Projections. New England Journal of Medicine, 371, 1481-1495.
Zacharowski, K., Brodt, H.R. y Wolf, T. (2015). Medical treatment of an Ebola-infected doctor-ethics over costs? The Lancet, 385(9969), 685. https://doi.org/10.1016/S0140-6736(15)60279-3
